Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum

被引：12
|
作者：
Shareef, M. S. [1 ]
Munro, L. R. [2 ]
Owen, R. G. [3 ]
Highet, A. S. [1 ]
机构：
[1] York Teaching Hosp, Dept Dermatol, York, N Yorkshire, England
[2] York Teaching Hosp, Dept Haematol, York, N Yorkshire, England
[3] St James Univ Hosp, HMDS Lab, Leeds, W Yorkshire, England
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2012年 / 37卷 / 02期
关键词：
MULTIPLE-MYELOMA; MONOCLONAL GAMMOPATHY; CRITERIA;
D O I：
10.1111/j.1365-2230.2011.04219.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Pyoderma gangrenosum (PG) may be associated with inflammatory disorders and haematological conditions such as monoclonal gammopathy of uncertain significance (MGUS). We report the case of a 53-year old man who had PG and MGUS. After treatment with infliximab for the PG, he developed myeloma. The course of events in this case suggests that infliximab facilitated the progression from MGUS to myeloma.
引用
收藏
页码：146 / 148
页数：3
相关论文
共 50 条
  • [21] Progression of Monoclonal Gammopathy with Undetermined Significance to Multiple Myeloma Diagnosed by Kidney Biopsy: A Case Report
    Kim, Jin Hae
    Kim, Ji Won
    Kim, Young Nam
    Kim, Hye In
    Kim, Jun Young
    Kwon, Ghee Young
    Kim, Kihyun
    Jang, Hye Ryoun
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2015, 5 (03): : 180 - 186
  • [22] Is It Possible to Predict Tumor Progression Through Genomic Characterization of Monoclonal Gammopathy and Smoldering Multiple Myeloma?
    Testa, Ugo
    Leone, Giuseppe
    Pelosi, Elvira
    Castelli, Germana
    De Stefano, Valerio
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [23] Facial Rash following Infliximab Treatment Reply
    Wolfe, Frederick
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (02) : 453 - 453
  • [24] Pyoderma Gangrenosum After Breast Surgery Diagnostic Pearls and Treatment Recommendations Based on a Systematic Literature Review
    Tuffaha, Sami H.
    Sarhane, Karim A.
    Mundinger, Gerhard S.
    Broyles, Justin M.
    Reddy, Sashank K.
    Azoury, Said C.
    Seal, Stella
    Cooney, Damon S.
    Bonawitz, Steven C.
    ANNALS OF PLASTIC SURGERY, 2016, 77 (02) : E39 - E44
  • [25] Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites
    Greenberg, A. J.
    Vachon, C. M.
    Rajkumar, S. V.
    LEUKEMIA, 2012, 26 (04) : 609 - 614
  • [26] Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients
    Widad Tahiru
    Antonio Izarra Santamaria
    Johan Hultdin
    Wendy Yi-Ying Wu
    Florentin Späth
    Experimental Hematology & Oncology, 11
  • [27] Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites
    A J Greenberg
    C M Vachon
    S V Rajkumar
    Leukemia, 2012, 26 : 609 - 614
  • [28] Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients
    Tahiru, Widad
    Izarra Santamaria, Antonio
    Hultdin, Johan
    Wu, Wendy Yi-Ying
    Spath, Florentin
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [29] Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma
    Tomasson, Michael H.
    Ali, Mahmoud
    De Oliveira, Vanessa
    Xiao, Qian
    Jethava, Yogesh
    Zhan, Fenghuang
    Fitzsimmons, Adam M.
    Bates, Melissa L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [30] Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients
    Steiner, Normann
    Goebel, Georg
    Suchecki, Patricia
    Prokop, Wolfgang
    Neuwirt, Hannes
    Gunsilius, Eberhard
    ONCOTARGET, 2018, 9 (02) : 2344 - 2356
12345